Your browser doesn't support javascript.
loading
Histological characteristics of lung adenocarcinoma with uncommon actionable alterations: special emphasis on MET exon 14 skipping alterations.
Hayashi, Takuo; Kohsaka, Shinji; Takamochi, Kazuya; Kishikawa, Satsuki; Ikarashi, Daiki; Sano, Kei; Hara, Kieko; Onagi, Hiroko; Suehara, Yoshiyuki; Takahashi, Fumiyuki; Saito, Tsuyoshi; Nakatsura, Tetsuya; Kitano, Shigehisa; Suzuki, Kenji; Yao, Takashi.
Afiliação
  • Hayashi T; Department of Human Pathology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Kohsaka S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Takamochi K; Department of General Thoracic Surgery, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Kishikawa S; Department of Human Pathology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Ikarashi D; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Sano K; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Hara K; Department of Human Pathology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Onagi H; Department of Human Pathology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Suehara Y; Department of Orthopedic Surgery, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Takahashi F; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Saito T; Department of Human Pathology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Nakatsura T; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Kitano S; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Suzuki K; Division of Cancer Immunotherapy Development, Advanced Medical Development Center, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Yao T; Department of General Thoracic Surgery, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Histopathology ; 78(7): 987-999, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33249657
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-met / Fator Nuclear 1 de Tireoide / Adenocarcinoma de Pulmão Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Histopathology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-met / Fator Nuclear 1 de Tireoide / Adenocarcinoma de Pulmão Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Histopathology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão